The Department of Health and Human Services will terminate contracts and funding for 22 vaccine development projects related to respiratory viruses like COVID-19 and flu. These projects, totaling $500 million, primarily utilize mRNA technology and involve major pharmaceutical companies, including Pfizer and Moderna, which are recognized for their roles in combating the 2020 coronavirus pandemic. Health Secretary Robert F. Kennedy Jr. expressed a wish to transition the department's focus away from mRNA vaccines towards alternative technologies, though specifics were not provided.
Health and Human Services will cancel contracts and pull funding for some vaccines being developed to fight respiratory viruses, totaling $500 million in mRNA technology projects.
Secretary Robert F. Kennedy Jr. announced the decision, stating a desire for the health department to move away from mRNA vaccines and invest in better solutions.
Collection
[
|
...
]